Puppy Vaccination Schedule: A young dog is referred as puppy. A puppy should be monitored for diseases and its vaccination schedule must start when it is 5 weeks old. It should be given vaccination for parvovirus which proves high risk of exposure to parvo. Between six and eight weeks after its birth, the puppy should be examined comprehensively. The examination must include fecal exam also. Heartworm preventive dosage must be administered based on the weight of the puppy. Deworming should also be performed on every visit. The Booster vaccine is also administered. Even combination vaccine of leptospirosis and coronavirus is
administered. Between ten and twelve weeks, the puppy should be physically examined. It requires the second dosage of Puppy Booster Duramune Max 5-CVK.
The main concern here is for the Heartworm Preventative, Bordetella - Bronchi-Shield III, and Deworming - Nemex II. Between fifteen and sixteen weeks, again the puppy must be examined
physically with the administration of Puppy Booster Duramune Max 5-CVK. Again at
the twentieth week, the puppy must be administered with Booster vaccine apart
from physical examination. There are many other vaccinations for puppies for the
following diseases.
- Leptospirosis – It is
a bacterial disease of the urinary system
- Corona – It is a
viral disease of the intestines
- Parainfluenza – It is
an infectious bronchitis disease.
- Parvovirus – It is a
viral disease of the intestines
- Rabies – It is a
viral disease fatal to humans and other animals
- Distemper – It is an
airborne viral disease of the lungs, intestines and brain
- Hepatitis – It is a
viral disease of the liver
- Bordetella – It is a
bacterial infection (kennel cough)
Dog Vacinatin Schedule:
Dog vaccines can be classified mainly into two classes such as core vaccines
and non-core vaccines. The core vaccines are the compulsory vaccines for all
dogs whereas the non-core vaccines are specific to certain dogs based on its
age, breed and health status.
Core Vaccines:
Canine Distemper vaccine which has high efficacy and low risk adverse effect. Its length of immunity is for 1
year. Parvovirus vaccine has high efficacy and 1 year length of immunity with low risks.
Hepatitis vaccine has high efficacy, low risks with length of immunity of 1 year.
Rabies vaccine has high efficacy and the length of immunity depends on the type of vaccine. The risk factors are
low to moderate.
Non-Core Vaccines: Measles vaccine is good in preventing the disease, but not in preventing the infection. It has long length of immunity and infrequent risk adverse effect.
Respiratory disease from canine adenovirus-2 (CAV-2) vaccine has short length of immunity and the risk of
adverse effect is minimal.
Parainfluenza vaccine has intranasal MLV - Moderate Injectable MLV with low efficacy. The length of
immunity is moderate with low adverse effects.
Bordetella vaccine has intranasal MLV - Moderate Injectable MLV with low efficacy. It has short length of immunity with low adverse effects.
Leptospirosis vaccine has variable efficacy with short length of immunity and high adverse effects.
Coronavirus vaccine has low efficacy, short length of immunity and low risks.
Lyme vaccine has variable efficacy and requires to be vaccinated every year with moderate risk effects.
Child Vacination schedule: The childhood vaccinations include the following.
Baby Vaccines from Birth to 2 months
Diphtheria, tetanus and acellular
pertussis (DTaP) — dose 1 of 5
Haemophilus influenzae type b (Hib)
— dose 1 of 4
Inactivated poliovirus (IPV) —
dose 1 of 4
Pneumococcal conjugate (PCV7) —
dose 1 of 4
Baby Vaccine before 4 months
Hepatitis B — doses 1 and 2 of 3
Baby Vaccines at 4 months
Diphtheria, tetanus and acellular pertussis (DTaP) — dose 2 of 5
Haemophilus influenzae type b (Hib) — dose 2 of 4
Inactivated poliovirus (IPV) — dose 2 of 4
Pneumococcal conjugate (PCV7) —dose 2 of 4
Baby Vaccines at 6 months
Diphtheria, tetanus and acellular pertussis (DTaP) — dose 3 of 5
Haemophilus influenzae type b (Hib) — dose 3 of 4
Pneumococcal conjugate (PCV7) — dose 3 of 4
Child Vaccines between 6 months and 18 months
Hepatitis B — dose 3 of 3
Inactivated poliovirus (IPV) — dose 3 of 4
Child Vaccines between 6 months and 59 months
Influenza — annual dose
Child Vaccines between 12 months and 15 months
Haemophilus influenzae type b (Hib) — dose 4 of 4
Pneumococcal conjugate (PCV7) — dose 4 of 4
Measles-mumps-rubella (MMR) — dose 1 of 2
Chickenpox (varicella) — dose 1 of 1
Child Vaccines between 12 months and 23 months
Hepatitis A — 2 doses
Child Vaccines between 15 months and 18 months
Diphtheria, tetanus and acellular pertussis (DTaP) — dose 4 of 5
Vaccines between 4 years and 6 years
Diphtheria, tetanus and acellular pertussis (DTaP) — dose 5 of 5
Inactivated poliovirus (IPV) — dose 4 of 4
Measles-mumps-rubella (MMR) — dose 2 of 2
Vaccines between 11 years and 12 years
Tetanus toxoid
Meningococcal conjugate vaccine (MCV4) — 1 dose
Vaccines between 11 years and 26 years
Human papillomavirus vaccine
Pet Vaccination Schedule:
Pet vaccines are important as they trigger protective immune responses in pets and prepare them to fight future infections.
The vaccinations are mainly based on the the pet’s age, health, lifestyle, environment, and geographic locations. Apart from the dog vaccination, the cat vaccinations are as follows.
Vaccine:
Panleukopenia, Herpesvirus and calicivirus (combined)- Administered as early as 6 weeks, with boosters every 3 to 4 weeks until at least 12 weeks of age.
Vaccine:
Feline infectious peritonitis (FIP) started at 4 months and repeated in 2-4 weeks. Vaccine: Feline distemper administered at 9 weeks old and 12 weeks old. Booster vaccination is also required.
J-Consortium is an open and democratic body organized as a not-for-profit consortium. We welcome as members all individuals and all companies from all viewpoints. Our posted publicly on our web site, explain the details of our organization, which is based on a one-company, one-vote principle for all technical decisions. J Consortium is an outgrowth of the Real-Time Java™ Working Group (RTJWG) on health application, which itself was an outgrowth of the NIST real-time requirements effort initiated in early 1998. Our specifications will be consistent with the NIST requirements. Our charter is to help to advance the creation of specifications and related activities for what we refer to as real-time and embedded extensions for Java Technologies. (Sun Microsystems defines “Java Technologies” to include the Java virtual machine, Java programming language, and class libraries.) In addition, when we refer to “real-time”, we mean real-time and embedded applications in medicine, with a special significance to the extreme doctors needs.